Abstract
Molar pregnancy and gestational trophoblastic neoplasia (GTN) comprise a group of interrelated diseases, including complete and partial molar pregnancy, placental-site trophoblastic tumor (PSTT), and choriocarcinoma, that have varying propensities for local invasion and distal spread. Vaginal bleeding is a common presenting sign, seen in as many as 97% of women with a complete molar pregnancy; it is also a frequent symptom of all types of GTN [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berkowitz RS, Goldstein DP, Bernstein MR. Evolving concepts of molar pregnancy. J Reprod Med. 1991;36(1):40–4.
Yamashita K, Wake N, Araki T, Ichinoe K, Makoto K. Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm. Am J Obstet Gynecol. 1979;135(5):597–600.
Keep D, Zaragoza MV, Hassold T, Redline RW. Very early complete hydatidiform mole. Hum Pathol. 1996;27(7):708–13.
Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol. 1978;132(1):20–7.
Berkowitz RS, Goldstein DP. Management of molar pregnancy and gestational trophoblastic tumors. In: Knapp RC, Berkowitz RS, editors. Gynecologic oncology. New York: McGraw Hill; 1993. p. 328.
Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000;16(2):188–91.
Romero R, Horgan JG, Kohorn EI, Kadar N, Taylor KJ, Hobbins JC. New criteria for the diagnosis of gestational trophoblastic disease. Obstet Gynecol. 1985;66(4):553–8.
Genest DR, Laborde O, Berkowitz RS, Goldstein DP, Bernstein MR, Lage J. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980–1990): histologic grade lacks prognostic significance. Obstet Gynecol. 1991;78(3 Pt 1):402–9.
Menczer J, Modan M, Serr DM. Prospective follow-up of patients with hydatidiform mole. Obstet Gynecol. 1980;55(3):346–9.
Thaker HM, Berlin A, Tycko B, et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004;49(8):630–6.
Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol. 1975;45(1):1–8.
Kohorn EI. Theca lutein ovarian cyst may be pathognomonic for trophoblastic neoplasia. Obstet Gynecol. 1983;62(3 Suppl):80s–1s.
Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995;86(5):775–9.
Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol. 1985;66(5):677–81.
Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989;73(3 Pt 1):414–8.
Osathanondh R, Berkowitz RS, de Cholnoky C, Smith BS, Goldstein DP, Tyson JE. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med. 1986;31(3):179–83.
Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335(23):1740–8.
Hancock BW, Tidy JA. Current management of molar pregnancy. J Reprod Med. 2002;47(5):347–54.
Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010;55(5–6):208–12.
Orr Jr JW, Austin JM, Hatch KD, Shingleton HM, Younger JB, Boots LR. Acute pulmonary edema associated with molar pregnancies: a high-risk factor for development of persistent trophoblastic disease. Am J Obstet Gynecol. 1980;136(3):412–5.
Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995;22(2):157–60.
Kim DS, Moon H, Kim KT, Moon YJ, Hwang YY. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol. 1986;67(5):690–4.
Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med. 2001;46(2):110–6.
van Trommel NE, Massuger LF, Verheijen RH, Sweep FC, Thomas CM. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol. 2005;99(1):6–13.
Pezeshki M, Hancock BW, Silcocks P, et al. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol. 2004;95(3):423–9.
Goldstein DP, Garner EI, Feltmate CM, Berkowitz RS. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol. 2004;95(3):421–2.
Wolfberg AJ, Growdon WB, Feltmate CM, et al. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol. 2006;108(2):393–6.
Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009;360(16):1639–45.
Kohorn EI. Persistent low-level “real” human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol Oncol. 2002;85(2):315–20.
Stone M, Bagshawe KD. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol. 1979;86(10):782–92.
Curry SL, Schlaerth JB, Kohorn EI, et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). Am J Obstet Gynecol. 1989;160(4):805–9. discussion 809–11.
Berkowitz RS, Goldstein DP, Marean AR, Bernstein M. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol. 1981;58(4):474–7.
Costa HL, Doyle P. Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia–a systematic review. Gynecol Oncol. 2006;100(3):579–85.
Gaffield ME, Kapp N, Curtis KM. Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease. Contraception. 2009;80(4):363–71.
Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008;53(7):481–6.
Clark RM, Nevadunsky NS, Ghosh S, Goldstein DP, Berkowitz RS. The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2010;55(5–6):194–8.
Alazzam M, Hancock BW, Tidy J. Role of hysterectomy in managing persistent gestational trophoblastic disease. J Reprod Med. 2008;53(7):519–24.
Cagayan MS, Magallanes MS. The role of adjuvant surgery in the management of gestational trophoblastic neoplasia. J Reprod Med. 2008;53(7):513–8.
Dobson LS, Gillespie AM, Coleman RE, Hancock BW. The presentation and management of post-partum choriocarcinoma. Br J Cancer. 1999;79(9–10):1531–3.
Berry E, Hagopian GS, Lurain JR. Vaginal metastases in gestational trophoblastic neoplasia. J Reprod Med. 2008;53(7):487–92.
Cagayan MS. Vaginal metastases complicating gestational trophoblastic neoplasia. J Reprod Med. 2010;55(5–6):229–35.
Yingna S, Yang X, Xiuyu Y, Hongzhao S. Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis. Gynecol Oncol. 2002;84(3):416–9.
Cockshott WP, Hendrickse JP. Persistent arteriovenous fistulae following chemotherapy of malignant trophoblastic disease. Radiology. 1967;88(2):329–33.
Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Holden L, Dent J. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979–1984). Br J Obstet Gynaecol. 1986;93(1):63–9.
McIvor J, Cameron EW. Pregnancy after uterine artery embolization to control haemorrhage from gestational trophoblastic tumour. Br J Radiol. 1996;69(823):624–9.
Lim AK, Agarwal R, Seckl MJ, Newlands ES, Barrett NK, Mitchell AW. Embolization of bleeding residual uterine vascular malformations in patients with treated gestational trophoblastic tumors. Radiology. 2002;222(3):640–4.
Garner EI, Meyerovitz M, Goldstein DP, Berkowitz RS. Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor. Gynecol Oncol. 2003;88(1):69–72.
Gillespie AM, Liyim D, Goepel JR, Coleman RE, Hancock BW. Placental site trophoblastic tumour: a rare but potentially curable cancer. Br J Cancer. 2000;82(6):1186–90.
Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717–29.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Barroilhet, L.M., Goldstein, D.P., Berkowitz, R.S. (2011). Vaginal Bleeding and Gestational Trophoblastic Disease. In: Sheiner, E. (eds) Bleeding During Pregnancy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9810-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9810-1_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9809-5
Online ISBN: 978-1-4419-9810-1
eBook Packages: MedicineMedicine (R0)